146 related articles for article (PubMed ID: 38388153)
21. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
22. Ocular copper deposition associated with monoclonal gammopathy of undetermined significance: case report.
Tzelikis PF; Laibson PR; Ribeiro MP; Rapuano CJ; Hammersmith KM; Cohen EJ
Arq Bras Oftalmol; 2005; 68(4):539-41. PubMed ID: 16322842
[TBL] [Abstract][Full Text] [Related]
23. Crystalline deposits in the cornea and various areas of the kidney as symptoms of an underlying monoclonal gammopathy: a case report.
Lindemann C; Enders P; Brinkkoetter PT; Völker LA
BMC Nephrol; 2021 Apr; 22(1):117. PubMed ID: 33823814
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal gammopathy of cutaneous significance.
Hussain K; Mehta D; Patel P; Roberts N
Clin Exp Dermatol; 2022 Apr; 47(4):778. PubMed ID: 34905231
[No Abstract] [Full Text] [Related]
25. Monoclonal gammopathy of renal significance: Early diagnosis is key.
Alonso-Titos J; Martínez-Esteban MD; López V; León M; Martin-Reyes G; Ruiz-Esteban P; Hernández D
Nefrologia (Engl Ed); 2021; 41(5):502-513. PubMed ID: 36165133
[TBL] [Abstract][Full Text] [Related]
26. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
27. [Current role of the laboratory in the demonstration and follow up of monoclonal immunoglobulinopathy].
Myara I
Pathol Biol (Paris); 1990 Feb; 38(2):134-43. PubMed ID: 2107510
[TBL] [Abstract][Full Text] [Related]
28. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
29. A Man With Bilateral Corneal Verticillata and Corneal Crystals.
Bhat A; Jhanji V
JAMA Ophthalmol; 2020 May; 138(5):580-581. PubMed ID: 32134430
[No Abstract] [Full Text] [Related]
30. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
31. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
[TBL] [Abstract][Full Text] [Related]
32. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
33. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
[TBL] [Abstract][Full Text] [Related]
34. Crystalglobulinemia manifested as acute renal failure and thrombotic vasculopathy.
Gómez-Lechón Quirós L; Acosta De La Vega ME; Compán Fernández O; Pastor Navarro S; Montilla Morales C; Moyano Bueno D; Martín Centellas J; Santos-Briz Terrón A; Hidalgo Calleja C
Rheumatol Int; 2020 Aug; 40(8):1327-1332. PubMed ID: 32533290
[TBL] [Abstract][Full Text] [Related]
35. Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation.
Shimamura Y; Maeda T; Ogawa Y; Nagai Y; Shinohara T; Takizawa H
CEN Case Rep; 2020 May; 9(2):109-113. PubMed ID: 31838713
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal gammopathy of thrombotic/thrombocytopenic significance.
Kanack AJ; Schaefer JK; Sridharan M; Splinter NP; Kohlhagen MC; Singh B; De Lorenzo SB; Mauch EE; Hussein MA; Shaikh M; Kumar S; Wen R; Wang D; Murray D; Padmanabhan A
Blood; 2023 Apr; 141(14):1772-1776. PubMed ID: 36626584
[No Abstract] [Full Text] [Related]
37. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.
Yoshida Y; Oguma S; Ohno H; Nakabo Y; Katsurada T; Kawahara M; Kawabata H
Int J Hematol; 2014 Jun; 99(6):721-5. PubMed ID: 24687918
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal gammopathy of undetermined significance (MGUS) manifestation in CNS: a regular or chance occurrence?
Prakhova L; Lebedev V; Ilves A; Nazinkina Y
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762271
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
40. AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?
Terré A; Colombat M; Cez A; Martin C; Diet C; Brechignac S; Oghina S; Bodez D; Faguer S; Savey L; Galland J; Boffa JJ; Grateau G; Jaccard A; Buob D; Georgin-Lavialle S
Int J Clin Pract; 2021 Nov; 75(11):e14817. PubMed ID: 34490695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
